PresentationIan MortimerInterim CFO, President, CEO, Principal Financial Officer, Principal Accounting Officer & Director Good morning, everyone. My name is Ian Mortimer, I'm the President and CEO of Xenon Pharmaceuticals, and I will be moderating today's session. Thank you for joining us on this investor webinar focused on our Kv7 and Nav1.7 programs in the development for the treatment of pain. Before diving into the speaker introductions and agenda for today, please note the standard notice that we wil ...